Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y M Peng

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1984
Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxiaC U Ludwig, Y M Peng, J N Beaudry, et al.
Neuroendocrinology|January 1, 1976
Changes in the nuclear volume of rat hypothalamic neurons in old ageK H Lin, Y M Peng, M T Peng, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The disposition of intraperitoneal bleomycin, melphalan, and vinblastine in cancer patientsD S Alberts, H S Chen, S Y Chang, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 17, 2007
Fatty acid composition in breast milk and serum phospholipids of healthy term Chinese infants during first 6 weeks of lifeY M Peng, T Y Zhang, Q Wang, et al.
Journal of Chromatographic Science|November 1, 1982
HPLC, MS, and pharmacokinetics of melphalan, bisantrene and 13-cis retinoic acidT P Davis, Y M Peng, G E Goodman, et al.
European Review for Medical and Pharmacological Sciences|April 25, 2020
Association of disease condition with changes in intestinal flora, and plasma endotoxin and vascular endothelial growth factor levels in patients with liver cancerN Jiang, X Song, Y-M Peng, et al.
British Journal of Cancer|August 1, 1978
Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouseD S Alberts, Y M Peng, H S Chen, et al.
European Review for Medical and Pharmacological Sciences|July 30, 2015
Vascular endothelial growth factor increases GEnC permeability by affecting the distributions of occludin, ZO-1 and tight juction assemblyL Zhang, H Liu, Y-M Peng, et al.
Cancer Research|October 1, 1985
Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantreneG T Bowden, R Roberts, D S Alberts, et al.
Cancer Treatment Reviews|December 1, 1983
Disposition of mitoxantrone in patientsD S Alberts, Y M Peng, S Leigh, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1984
Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxiaC U Ludwig, Y M Peng, J N Beaudry, et al.
Neuroendocrinology|January 1, 1976
Changes in the nuclear volume of rat hypothalamic neurons in old ageK H Lin, Y M Peng, M T Peng, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The disposition of intraperitoneal bleomycin, melphalan, and vinblastine in cancer patientsD S Alberts, H S Chen, S Y Chang, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 17, 2007
Fatty acid composition in breast milk and serum phospholipids of healthy term Chinese infants during first 6 weeks of lifeY M Peng, T Y Zhang, Q Wang, et al.
Journal of Chromatographic Science|November 1, 1982
HPLC, MS, and pharmacokinetics of melphalan, bisantrene and 13-cis retinoic acidT P Davis, Y M Peng, G E Goodman, et al.
European Review for Medical and Pharmacological Sciences|April 25, 2020
Association of disease condition with changes in intestinal flora, and plasma endotoxin and vascular endothelial growth factor levels in patients with liver cancerN Jiang, X Song, Y-M Peng, et al.
British Journal of Cancer|August 1, 1978
Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouseD S Alberts, Y M Peng, H S Chen, et al.
European Review for Medical and Pharmacological Sciences|July 30, 2015
Vascular endothelial growth factor increases GEnC permeability by affecting the distributions of occludin, ZO-1 and tight juction assemblyL Zhang, H Liu, Y-M Peng, et al.
Cancer Research|October 1, 1985
Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantreneG T Bowden, R Roberts, D S Alberts, et al.
Cancer Treatment Reviews|December 1, 1983
Disposition of mitoxantrone in patientsD S Alberts, Y M Peng, S Leigh, et al.
Pageof 9